var data={"title":"Pulmonary arteriovenous malformations: Epidemiology, etiology, and pathology in adults","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Pulmonary arteriovenous malformations: Epidemiology, etiology, and pathology in adults</div><dl id=\"topicContributors\"><dt><span> </span>Author:</dt><dd><a href=\"https://www.uptodate.com/contents/pulmonary-arteriovenous-malformations-epidemiology-etiology-and-pathology-in-adults/contributors\" class=\"contributor contributor_credentials\">James R Gossage, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/pulmonary-arteriovenous-malformations-epidemiology-etiology-and-pathology-in-adults/contributors\" class=\"contributor contributor_credentials\">Jess Mandel, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/pulmonary-arteriovenous-malformations-epidemiology-etiology-and-pathology-in-adults/contributors\" class=\"contributor contributor_credentials\">Geraldine Finlay, MD</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/pulmonary-arteriovenous-malformations-epidemiology-etiology-and-pathology-in-adults/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Jun 14, 2017.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H1\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Pulmonary arteriovenous malformations (PAVMs) are abnormal communications between pulmonary arteries and veins [<a href=\"https://www.uptodate.com/contents/pulmonary-arteriovenous-malformations-epidemiology-etiology-and-pathology-in-adults/abstract/1\" class=\"abstract_t\">1</a>]. Alternative names include pulmonary arteriovenous fistulae, pulmonary arteriovenous aneurysms, cavernous angiomas of the lung, and pulmonary telangiectases [<a href=\"https://www.uptodate.com/contents/pulmonary-arteriovenous-malformations-epidemiology-etiology-and-pathology-in-adults/abstract/2\" class=\"abstract_t\">2</a>]. PAVMs are uncommon in the general population, but they are an important consideration in the differential diagnosis of common pulmonary problems, including hypoxemia, pulmonary nodules, and hemoptysis. In addition, they are a common occurrence in patients with hereditary hemorrhagic telangiectasia (HHT, also called Osler-Weber-Rendu syndrome).</p><p>The epidemiology, etiology, pathology, clinical features, and natural course of PAVMs are reviewed here. The diagnosis and treatment of PAVMs are discussed separately. (See <a href=\"topic.htm?path=pulmonary-arteriovenous-malformations-clinical-features-and-diagnostic-evaluation-in-adults\" class=\"medical medical_review\">&quot;Pulmonary arteriovenous malformations: Clinical features and diagnostic evaluation in adults&quot;</a> and <a href=\"topic.htm?path=therapeutic-approach-to-adult-patients-with-pulmonary-arteriovenous-malformations\" class=\"medical medical_review\">&quot;Therapeutic approach to adult patients with pulmonary arteriovenous malformations&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H2\"><span class=\"h1\">EPIDEMIOLOGY</span></p><p class=\"headingAnchor\" id=\"H177426868\"><span class=\"h2\">General population</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Pulmonary arteriovenous malformations (PAVMs) are uncommon in the general population. This was illustrated by a study of 15,000 consecutive autopsies, in which only three cases of PAVMs were detected [<a href=\"https://www.uptodate.com/contents/pulmonary-arteriovenous-malformations-epidemiology-etiology-and-pathology-in-adults/abstract/2\" class=\"abstract_t\">2</a>]. Three additional case series from the Mayo Clinic suggested a similar low rate of PAVMs in the general population reporting 194 cases of PAVMs over 45 years (ie, 4.3 cases per year) [<a href=\"https://www.uptodate.com/contents/pulmonary-arteriovenous-malformations-epidemiology-etiology-and-pathology-in-adults/abstract/3-5\" class=\"abstract_t\">3-5</a>]. </p><p>PAVMs are 1.5 to 2 times as common among women, compared with men [<a href=\"https://www.uptodate.com/contents/pulmonary-arteriovenous-malformations-epidemiology-etiology-and-pathology-in-adults/abstract/6\" class=\"abstract_t\">6</a>]. </p><p>In patients that have PAVMs, they are commonly multiple, and vary in their number, distribution, and size. As an example, in one retrospective study of 350 patients with PAVMs, 36 percent of patients had multiple lesions and 25 percent had bilateral disease [<a href=\"https://www.uptodate.com/contents/pulmonary-arteriovenous-malformations-epidemiology-etiology-and-pathology-in-adults/abstract/7\" class=\"abstract_t\">7</a>]. More than half of the lesions were in the lower lung fields and almost 80 percent involved the pleura. In another study of 112 patients who underwent embolization of PAVM, 67 percent had multiple PAVMs and 92 percent were in the lower lobes [<a href=\"https://www.uptodate.com/contents/pulmonary-arteriovenous-malformations-epidemiology-etiology-and-pathology-in-adults/abstract/8\" class=\"abstract_t\">8</a>]. Other retrospective series indicate that PAVMs are typically 1 to 5 cm in size (but occasionally exceed 10 cm) and that 7 to 11 percent of patients have diffuse microvascular PAVMs that may occur in combination with radiographically visible PAVMs [<a href=\"https://www.uptodate.com/contents/pulmonary-arteriovenous-malformations-epidemiology-etiology-and-pathology-in-adults/abstract/5,9,10\" class=\"abstract_t\">5,9,10</a>]. PAVMs tend to increase slowly in size over time and rarely regress spontaneously.</p><p class=\"headingAnchor\" id=\"H177426874\"><span class=\"h2\">Hereditary hemorrhagic telangiectasia (HHT)</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Reports suggest that in patients with PAVMs, the rate of hereditary hemorrhagic telangiectasia (HHT, also called Osler-Weber-Rendu syndrome) ranges from 25 to 98 percent. While it was previously estimated that 70 percent of cases of PAVM were associated with HHT [<a href=\"https://www.uptodate.com/contents/pulmonary-arteriovenous-malformations-epidemiology-etiology-and-pathology-in-adults/abstract/11\" class=\"abstract_t\">11</a>], reports from HHT treatment centers report higher rates of at least 94 to 96 percent [<a href=\"https://www.uptodate.com/contents/pulmonary-arteriovenous-malformations-epidemiology-etiology-and-pathology-in-adults/abstract/8,12,13\" class=\"abstract_t\">8,12,13</a>]. In our experience with over 200 patients with PAVM, HHT was either confirmed or strongly suspected in at least 98 percent of the patients with macroscopic PAVM. In contrast, a study from Japan performed low dose CT to screen for lung cancer in 21,235 patients and found eight cases of PAVM, only two of which were due to HHT [<a href=\"https://www.uptodate.com/contents/pulmonary-arteriovenous-malformations-epidemiology-etiology-and-pathology-in-adults/abstract/14\" class=\"abstract_t\">14</a>]. This latter study suggests that only 25 percent of PAVMs seen outside of HHT referral centers are associated with HHT. We await additional studies for true estimates on the incidence of HHT in patients with PAVM. </p><p>Approximately 11 to 40 percent of patients with HHT have visible PAVMs on chest CT [<a href=\"https://www.uptodate.com/contents/pulmonary-arteriovenous-malformations-epidemiology-etiology-and-pathology-in-adults/abstract/11,15-17\" class=\"abstract_t\">11,15-17</a>], although this appears to be substantially higher among patients with HHT1 due to an ENG mutation [<a href=\"https://www.uptodate.com/contents/pulmonary-arteriovenous-malformations-epidemiology-etiology-and-pathology-in-adults/abstract/18\" class=\"abstract_t\">18</a>]. Although HHT-associated PAVMs are uncommon during infancy, they may still be seen, and then gradually increase in incidence through the fifth and sixth decades of life [<a href=\"https://www.uptodate.com/contents/pulmonary-arteriovenous-malformations-epidemiology-etiology-and-pathology-in-adults/abstract/19\" class=\"abstract_t\">19</a>]. The largest study of screening for PAVM in 175 children with definite HHT found an incidence of 22 percent [<a href=\"https://www.uptodate.com/contents/pulmonary-arteriovenous-malformations-epidemiology-etiology-and-pathology-in-adults/abstract/20\" class=\"abstract_t\">20</a>]. Another study found that 13 percent of children with definite HHT had symptomatic PAVM and several of these presented before age 7, usually with hypoxia or cyanosis [<a href=\"https://www.uptodate.com/contents/pulmonary-arteriovenous-malformations-epidemiology-etiology-and-pathology-in-adults/abstract/21\" class=\"abstract_t\">21</a>].</p><p>Many specialized centers screen HHT patients for PAVMs to identify those who may benefit from therapy. For those too small for therapy on the initial screen, one retrospective study reported that five years later 18 percent of patients demonstrated lesions that had grown to a size that warranted embolization [<a href=\"https://www.uptodate.com/contents/pulmonary-arteriovenous-malformations-epidemiology-etiology-and-pathology-in-adults/abstract/22\" class=\"abstract_t\">22</a>]. Screening for PAVMs and the epidemiology and clinical manifestations of HHT are discussed separately. (See <a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-hereditary-hemorrhagic-telangiectasia-osler-weber-rendu-syndrome\" class=\"medical medical_review\">&quot;Clinical manifestations and diagnosis of hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu syndrome)&quot;</a> and <a href=\"topic.htm?path=therapeutic-approach-to-adult-patients-with-pulmonary-arteriovenous-malformations\" class=\"medical medical_review\">&quot;Therapeutic approach to adult patients with pulmonary arteriovenous malformations&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H3\"><span class=\"h1\">ETIOLOGY</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Most pulmonary arteriovenous malformations (PAVMs) are congenital and due to hereditary hemorrhagic telangiectasia (HHT). However PAVMs can occur in a variety of acquired medical conditions, the most common of which is hepatic cirrhosis (<a href=\"image.htm?imageKey=PULM%2F102807\" class=\"graphic graphic_table graphicRef102807 \">table 1</a>) [<a href=\"https://www.uptodate.com/contents/pulmonary-arteriovenous-malformations-epidemiology-etiology-and-pathology-in-adults/abstract/23\" class=\"abstract_t\">23</a>]. &#160;</p><p>Less common associations include penetrating chest trauma, mitral stenosis, schistosomiasis, actinomycosis, Fanconi's syndrome, and metastatic thyroid carcinoma [<a href=\"https://www.uptodate.com/contents/pulmonary-arteriovenous-malformations-epidemiology-etiology-and-pathology-in-adults/abstract/24,25\" class=\"abstract_t\">24,25</a>]. PAVMs are also a well-established complication following surgery for congenital heart disease in children, including the classic Glenn shunt [<a href=\"https://www.uptodate.com/contents/pulmonary-arteriovenous-malformations-epidemiology-etiology-and-pathology-in-adults/abstract/26\" class=\"abstract_t\">26</a>] and bidirectional cavopulmonary anastomosis [<a href=\"https://www.uptodate.com/contents/pulmonary-arteriovenous-malformations-epidemiology-etiology-and-pathology-in-adults/abstract/27\" class=\"abstract_t\">27</a>]. The mechanism by which these various medical conditions become associated with PAVM is unknown.</p><p>The remainder of PAVMs are believed to be idiopathic [<a href=\"https://www.uptodate.com/contents/pulmonary-arteriovenous-malformations-epidemiology-etiology-and-pathology-in-adults/abstract/28\" class=\"abstract_t\">28</a>]. </p><p>The genetics and pathogenesis of HHT, an autosomal dominant disorder of variable penetrance, may also provide insights into the etiology of PAVM, the details of which are discussed separately. (See <a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-hereditary-hemorrhagic-telangiectasia-osler-weber-rendu-syndrome#H5\" class=\"medical medical_review\">&quot;Clinical manifestations and diagnosis of hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu syndrome)&quot;, section on 'Pathophysiology'</a>.)</p><p class=\"headingAnchor\" id=\"H4\"><span class=\"h1\">PATHOLOGY</span></p><p class=\"headingAnchor\" id=\"H177426971\"><span class=\"h2\">Pathogenesis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The precise cause of pulmonary arteriovenous malformation (PAVM) is unknown. However, numerous causes of PAVM have been proposed, including the following: aberrant transforming growth factor-beta signaling during vascular development, possibly involving endoglin or activin receptor-like kinase 1; a defect in terminal arterial loops that allows dilation of thin-walled capillary sacs; incomplete resorption of the vascular septae that separate the arterial and venous plexuses during fetal development; failure of capillary development during fetal development, followed by the progressive dilation of favored limbs of smaller plexuses, formation of multiloculated sacs, and rupture of intervening vascular walls; and, development of many small PAVMs consisting of a single artery-to-vein connection without an intervening plexus [<a href=\"https://www.uptodate.com/contents/pulmonary-arteriovenous-malformations-epidemiology-etiology-and-pathology-in-adults/abstract/25\" class=\"abstract_t\">25</a>].</p><p class=\"headingAnchor\" id=\"H177426977\"><span class=\"h2\">Pathology</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>A PAVM is an abnormal connection between the pulmonary artery and pulmonary vein that lacks that normal capillary component that should exist between the pulmonary arterial and venous circulations of the lung. </p><p>A PAVM may appear macroscopically as a large, single or multi-lobulated sac, a plexiform mass of dilated vascular channels, or a dilated and tortuous direct anastomosis between an artery and vein [<a href=\"https://www.uptodate.com/contents/pulmonary-arteriovenous-malformations-epidemiology-etiology-and-pathology-in-adults/abstract/7\" class=\"abstract_t\">7</a>]. </p><p>Histologically, PAVMs are usually thin-walled, consisting of a single layer of endothelium and variable amounts of connective tissue stroma [<a href=\"https://www.uptodate.com/contents/pulmonary-arteriovenous-malformations-epidemiology-etiology-and-pathology-in-adults/abstract/2\" class=\"abstract_t\">2</a>]. Calcification and mural thrombosis are occasionally seen.</p><p>PAVMs are classified as either simple or complex. Simple PAVMs are perfused by arteries arising from a single subsegmental artery, whereas complex PAVMs are perfused by more than one subsegmental artery. Eighty to 95 percent of PAVMs are simple [<a href=\"https://www.uptodate.com/contents/pulmonary-arteriovenous-malformations-epidemiology-etiology-and-pathology-in-adults/abstract/28,29\" class=\"abstract_t\">28,29</a>]. Small microvascular PAVMs (ie, telangiectases) are most commonly of the complex type [<a href=\"https://www.uptodate.com/contents/pulmonary-arteriovenous-malformations-epidemiology-etiology-and-pathology-in-adults/abstract/30\" class=\"abstract_t\">30</a>]. </p><p>PAVMs are supplied by pulmonary arteries in about 95 percent of cases and are usually drained by pulmonary veins; however, they may occasionally be fed by systemic arteries (ie, the bronchial artery) <span class=\"nowrap\">and/or</span> drain into the left atrium or inferior vena cava. When PAVMs are fed by systemic arteries, hereditary hemorrhagic telangiectasia (HHT) is usually not the cause of the PAVM. </p><p class=\"headingAnchor\" id=\"H1843005\"><span class=\"h1\">SUMMARY</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Pulmonary arteriovenous malformations (PAVMs) are abnormal communications between pulmonary arteries and veins. PAVMs are an important consideration in the differential diagnosis of common pulmonary problems, including hypoxemia, pulmonary nodules, and hemoptysis. (See <a href=\"#H1\" class=\"local\">'Introduction'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>PAVMs are uncommon in the general population. They are more common among women compared with men. They are often multiple and vary in their number, distribution, and size. (See <a href=\"#H177426868\" class=\"local\">'General population'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Most PAVMs are associated with hereditary hemorrhagic telangiectasia (HHT, also called Osler-Weber-Rendu syndrome) with rates of underlying HHT ranging from 25 to 98 percent, with higher rates reported at HHT referral centers. In contrast, approximately 11 to 40 percent of patients with HHT have visible PAVMs on chest CT. (See <a href=\"#H177426874\" class=\"local\">'Hereditary hemorrhagic telangiectasia (HHT)'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Most PAVMs are congenital and due to HHT, PAVMs can occur in a variety of acquired medical conditions, the most common of which is hepatic cirrhosis (<a href=\"image.htm?imageKey=PULM%2F102807\" class=\"graphic graphic_table graphicRef102807 \">table 1</a>). Less common associations include penetrating chest trauma, mitral stenosis, schistosomiasis, actinomycosis, Fanconi's syndrome, and metastatic thyroid carcinoma. (See <a href=\"#H3\" class=\"local\">'Etiology'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The precise cause of PAVM is unknown. PAVMs macroscopically appear as a large single or multi-lobulated sac, a plexiform mass of dilated vascular channels, or a dilated and tortuous direct anastomosis between an artery and vein. Histologically, PAVMs are usually thin-walled, consisting of a single layer of endothelium and variable amounts of connective tissue stroma. Calcification and mural thrombosis are occasionally seen. (See <a href=\"#H4\" class=\"local\">'Pathology'</a> above.)</p><p/></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li><a href=\"https://www.uptodate.com/contents/pulmonary-arteriovenous-malformations-epidemiology-etiology-and-pathology-in-adults/abstract/1\" class=\"nounderline abstract_t\">Churton, T. Multiple aneurysms of the pulmonary artery. Br Med J 1897; 1:1223.</a></li><li><a href=\"https://www.uptodate.com/contents/pulmonary-arteriovenous-malformations-epidemiology-etiology-and-pathology-in-adults/abstract/2\" class=\"nounderline abstract_t\">SLOAN RD, COOLEY RN. Congenital pulmonary arteriovenous aneurysm. Am J Roentgenol Radium Ther Nucl Med 1953; 70:183.</a></li><li><a href=\"https://www.uptodate.com/contents/pulmonary-arteriovenous-malformations-epidemiology-etiology-and-pathology-in-adults/abstract/3\" class=\"nounderline abstract_t\">Swanson KL, Prakash UB, Stanson AW. Pulmonary arteriovenous fistulas: Mayo Clinic experience, 1982-1997. Mayo Clin Proc 1999; 74:671.</a></li><li><a href=\"https://www.uptodate.com/contents/pulmonary-arteriovenous-malformations-epidemiology-etiology-and-pathology-in-adults/abstract/4\" class=\"nounderline abstract_t\">Dines DE, Arms RA, Bernatz PE, Gomes MR. Pulmonary arteriovenous fistulas. Mayo Clin Proc 1974; 49:460.</a></li><li><a href=\"https://www.uptodate.com/contents/pulmonary-arteriovenous-malformations-epidemiology-etiology-and-pathology-in-adults/abstract/5\" class=\"nounderline abstract_t\">Dines DE, Seward JB, Bernatz PE. Pulmonary arteriovenous fistulas. Mayo Clin Proc 1983; 58:176.</a></li><li><a href=\"https://www.uptodate.com/contents/pulmonary-arteriovenous-malformations-epidemiology-etiology-and-pathology-in-adults/abstract/6\" class=\"nounderline abstract_t\">Cottin V, Dupuis-Girod S, Lesca G, Cordier JF. Pulmonary vascular manifestations of hereditary hemorrhagic telangiectasia (rendu-osler disease). Respiration 2007; 74:361.</a></li><li><a href=\"https://www.uptodate.com/contents/pulmonary-arteriovenous-malformations-epidemiology-etiology-and-pathology-in-adults/abstract/7\" class=\"nounderline abstract_t\">BOSHER LH Jr, BLAKE DA, BYRD BR. An analysis of the pathologic anatomy of pulmonary arteriovenous aneurysms with particular reference to the applicability of local excision. Surgery 1959; 45:91.</a></li><li><a href=\"https://www.uptodate.com/contents/pulmonary-arteriovenous-malformations-epidemiology-etiology-and-pathology-in-adults/abstract/8\" class=\"nounderline abstract_t\">Mager JJ, Overtoom TT, Blauw H, et al. Embolotherapy of pulmonary arteriovenous malformations: long-term results in 112 patients. J Vasc Interv Radiol 2004; 15:451.</a></li><li><a href=\"https://www.uptodate.com/contents/pulmonary-arteriovenous-malformations-epidemiology-etiology-and-pathology-in-adults/abstract/9\" class=\"nounderline abstract_t\">Kretschmar O, Ewert P, Yigitbasi M, et al. Huge pulmonary arteriovenous fistula: diagnosis and treatment and an unusual complication of embolization. Respir Care 2002; 47:998.</a></li><li><a href=\"https://www.uptodate.com/contents/pulmonary-arteriovenous-malformations-epidemiology-etiology-and-pathology-in-adults/abstract/10\" class=\"nounderline abstract_t\">White RI Jr, Lynch-Nyhan A, Terry P, et al. Pulmonary arteriovenous malformations: techniques and long-term outcome of embolotherapy. Radiology 1988; 169:663.</a></li><li><a href=\"https://www.uptodate.com/contents/pulmonary-arteriovenous-malformations-epidemiology-etiology-and-pathology-in-adults/abstract/11\" class=\"nounderline abstract_t\">Guttmacher AE, Marchuk DA, White RI Jr. Hereditary hemorrhagic telangiectasia. N Engl J Med 1995; 333:918.</a></li><li><a href=\"https://www.uptodate.com/contents/pulmonary-arteriovenous-malformations-epidemiology-etiology-and-pathology-in-adults/abstract/12\" class=\"nounderline abstract_t\">Pollak JS, Saluja S, Thabet A, et al. Clinical and anatomic outcomes after embolotherapy of pulmonary arteriovenous malformations. J Vasc Interv Radiol 2006; 17:35.</a></li><li><a href=\"https://www.uptodate.com/contents/pulmonary-arteriovenous-malformations-epidemiology-etiology-and-pathology-in-adults/abstract/13\" class=\"nounderline abstract_t\">Shovlin CL, Jackson JE, Bamford KB, et al. Primary determinants of ischaemic stroke/brain abscess risks are independent of severity of pulmonary arteriovenous malformations in hereditary haemorrhagic telangiectasia. Thorax 2008; 63:259.</a></li><li><a href=\"https://www.uptodate.com/contents/pulmonary-arteriovenous-malformations-epidemiology-etiology-and-pathology-in-adults/abstract/14\" class=\"nounderline abstract_t\">Nakayama M, Nawa T, Chonan T, et al. Prevalence of pulmonary arteriovenous malformations as estimated by low-dose thoracic CT screening. Intern Med 2012; 51:1677.</a></li><li><a href=\"https://www.uptodate.com/contents/pulmonary-arteriovenous-malformations-epidemiology-etiology-and-pathology-in-adults/abstract/15\" class=\"nounderline abstract_t\">Vase P, Holm M, Arendrup H. Pulmonary arteriovenous fistulas in hereditary hemorrhagic telangiectasia. Acta Med Scand 1985; 218:105.</a></li><li><a href=\"https://www.uptodate.com/contents/pulmonary-arteriovenous-malformations-epidemiology-etiology-and-pathology-in-adults/abstract/16\" class=\"nounderline abstract_t\">Haitjema T, Disch F, Overtoom TT, et al. Screening family members of patients with hereditary hemorrhagic telangiectasia. Am J Med 1995; 99:519.</a></li><li><a href=\"https://www.uptodate.com/contents/pulmonary-arteriovenous-malformations-epidemiology-etiology-and-pathology-in-adults/abstract/17\" class=\"nounderline abstract_t\">Plauchu H, de Chadar&eacute;vian JP, Bideau A, Robert JM. Age-related clinical profile of hereditary hemorrhagic telangiectasia in an epidemiologically recruited population. Am J Med Genet 1989; 32:291.</a></li><li><a href=\"https://www.uptodate.com/contents/pulmonary-arteriovenous-malformations-epidemiology-etiology-and-pathology-in-adults/abstract/18\" class=\"nounderline abstract_t\">van Gent MW, Post MC, Snijder RJ, et al. Real prevalence of pulmonary right-to-left shunt according to genotype in patients with hereditary hemorrhagic telangiectasia: a transthoracic contrast echocardiography study. Chest 2010; 138:833.</a></li><li><a href=\"https://www.uptodate.com/contents/pulmonary-arteriovenous-malformations-epidemiology-etiology-and-pathology-in-adults/abstract/19\" class=\"nounderline abstract_t\">Fuchizaki U, Miyamori H, Kitagawa S, et al. Hereditary haemorrhagic telangiectasia (Rendu-Osler-Weber disease). Lancet 2003; 362:1490.</a></li><li><a href=\"https://www.uptodate.com/contents/pulmonary-arteriovenous-malformations-epidemiology-etiology-and-pathology-in-adults/abstract/20\" class=\"nounderline abstract_t\">Hosman AE, de Gussem EM, Balemans WAF, et al. Screening children for pulmonary arteriovenous malformations: Evaluation of 18 years of experience. Pediatr Pulmonol 2017; 52:1206.</a></li><li><a href=\"https://www.uptodate.com/contents/pulmonary-arteriovenous-malformations-epidemiology-etiology-and-pathology-in-adults/abstract/21\" class=\"nounderline abstract_t\">Al-Saleh S, Mei-Zahav M, Faughnan ME, et al. Screening for pulmonary and cerebral arteriovenous malformations in children with hereditary haemorrhagic telangiectasia. Eur Respir J 2009; 34:875.</a></li><li><a href=\"https://www.uptodate.com/contents/pulmonary-arteriovenous-malformations-epidemiology-etiology-and-pathology-in-adults/abstract/22\" class=\"nounderline abstract_t\">Vorselaars VM, Velthuis S, Snijder RJ, et al. Follow-up of pulmonary right-to-left shunt in hereditary haemorrhagic telangiectasia. Eur Respir J 2016; 47:1750.</a></li><li><a href=\"https://www.uptodate.com/contents/pulmonary-arteriovenous-malformations-epidemiology-etiology-and-pathology-in-adults/abstract/23\" class=\"nounderline abstract_t\">Krowka MJ. Hepatopulmonary Syndrome and Portopulmonary Hypertension. Curr Treat Options Cardiovasc Med 2002; 4:267.</a></li><li><a href=\"https://www.uptodate.com/contents/pulmonary-arteriovenous-malformations-epidemiology-etiology-and-pathology-in-adults/abstract/24\" class=\"nounderline abstract_t\">Lange PA, Stoller JK. The hepatopulmonary syndrome. Ann Intern Med 1995; 122:521.</a></li><li><a href=\"https://www.uptodate.com/contents/pulmonary-arteriovenous-malformations-epidemiology-etiology-and-pathology-in-adults/abstract/25\" class=\"nounderline abstract_t\">Gossage JR, Kanj G. Pulmonary arteriovenous malformations. A state of the art review. Am J Respir Crit Care Med 1998; 158:643.</a></li><li><a href=\"https://www.uptodate.com/contents/pulmonary-arteriovenous-malformations-epidemiology-etiology-and-pathology-in-adults/abstract/26\" class=\"nounderline abstract_t\">Mathur M, Glenn WW. Long-term evaluation of cava-pulmonary artery anastomosis. Surgery 1973; 74:899.</a></li><li><a href=\"https://www.uptodate.com/contents/pulmonary-arteriovenous-malformations-epidemiology-etiology-and-pathology-in-adults/abstract/27\" class=\"nounderline abstract_t\">Kim SJ, Bae EJ, Cho DJ, et al. Development of pulmonary arteriovenous fistulas after bidirectional cavopulmonary shunt. Ann Thorac Surg 2000; 70:1918.</a></li><li><a href=\"https://www.uptodate.com/contents/pulmonary-arteriovenous-malformations-epidemiology-etiology-and-pathology-in-adults/abstract/28\" class=\"nounderline abstract_t\">Wong HH, Chan RP, Klatt R, Faughnan ME. Idiopathic pulmonary arteriovenous malformations: clinical and imaging characteristics. Eur Respir J 2011; 38:368.</a></li><li><a href=\"https://www.uptodate.com/contents/pulmonary-arteriovenous-malformations-epidemiology-etiology-and-pathology-in-adults/abstract/29\" class=\"nounderline abstract_t\">Pugash RA. Pulmonary arteriovenous malformations: overview and transcatheter embolotherapy. Can Assoc Radiol J 2001; 52:92.</a></li><li><a href=\"https://www.uptodate.com/contents/pulmonary-arteriovenous-malformations-epidemiology-etiology-and-pathology-in-adults/abstract/30\" class=\"nounderline abstract_t\">HALES MR. Multiple small arteriovenous fistulae of the lungs. Am J Pathol 1956; 32:927.</a></li></ol></div><div id=\"topicVersionRevision\">Topic 8267 Version 16.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H1843005\"><span>SUMMARY</span></a></li><li><a href=\"#H1\" id=\"outline-link-H1\">INTRODUCTION</a></li><li><a href=\"#H2\" id=\"outline-link-H2\">EPIDEMIOLOGY</a><ul><li><a href=\"#H177426868\" id=\"outline-link-H177426868\">General population</a></li><li><a href=\"#H177426874\" id=\"outline-link-H177426874\">Hereditary hemorrhagic telangiectasia (HHT)</a></li></ul></li><li><a href=\"#H3\" id=\"outline-link-H3\">ETIOLOGY</a></li><li><a href=\"#H4\" id=\"outline-link-H4\">PATHOLOGY</a><ul><li><a href=\"#H177426971\" id=\"outline-link-H177426971\">Pathogenesis</a></li><li><a href=\"#H177426977\" id=\"outline-link-H177426977\">Pathology</a></li></ul></li><li><a href=\"#H1843005\" id=\"outline-link-H1843005\">SUMMARY</a></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"PULM/8267|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=PULM/102807\" class=\"graphic graphic_table\">- Causes of pulmonary artery venous malformations</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-hereditary-hemorrhagic-telangiectasia-osler-weber-rendu-syndrome\" class=\"medical medical_review\">Clinical manifestations and diagnosis of hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu syndrome)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=pulmonary-arteriovenous-malformations-clinical-features-and-diagnostic-evaluation-in-adults\" class=\"medical medical_review\">Pulmonary arteriovenous malformations: Clinical features and diagnostic evaluation in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=therapeutic-approach-to-adult-patients-with-pulmonary-arteriovenous-malformations\" class=\"medical medical_review\">Therapeutic approach to adult patients with pulmonary arteriovenous malformations</a></li></ul></div></div>","javascript":null}